BURLINGTON, North Carolina & Aldie, Va. – Labcorpa leading global life sciences company, and Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, today announced a new collaboration to increase clinical trial diversity for women of color and co-create health equity solutions . Labcorp signed Tigerlily’s #InclusionPledge for Black Women, joining other healthcare and life sciences companies in committing to removing barriers for women of color in accessing care and research against the cancer. Together, Tigerlily and Labcorp will work to end health disparities through #InclusionPledge.
(Graphic: Business Wire)
“Race, literacy, financial barriers, access, social, systemic and hereditary background should not be determinants of equity in life and health. To continue to accelerate and make an impact when it comes to disparities and women of color, the #InclusionPledge is imperative. As an organization, Tigerlily Foundation was founded to fight against inequalities of age, stage and color. We have invested heavily in addressing the disparities affecting women of color, to ensure they are equal partners at every table and we will continue to do so. We are honored to have Labcorp support the #InclusionPledge because they are so closely associated with many initiatives that directly impact the future of patient care. We look forward to our relationship and continued activities to foster inclusion,” said Tigerlily Foundation CEO and Founder, Maimah Karmo.
#InclusionPledge’s mission is to champion and activate the inclusion of women of color in initiatives that impact global health. The Pledge provides a transparent and tangible framework for all industry and healthcare stakeholders that identifies and tracks equity actions, and holds organizations accountable for specific, measurable results that can lead to greater greater health equity for women of color. The #InclusionPledge aims to move stakeholders from discussion to transformation and to foster change and innovation.
This collaboration focuses on finding solutions to promote health equity for women of color and dismantle barriers that have made it difficult to access clinical trials.
“Making health accessible to all and fostering a corporate culture that embraces diversity is a priority at Labcorp,’ said Brenda Velazquez WagnerDirector of Diversity and Inclusion at Labcorp. “By signing the #InclusionPledge, we continue to support diversity in all areas of healthcare, especially in clinical trials, where a diverse population of participants provides valuable and needed insight into effective patient care. Labcorp is committed to inclusive clinical research and provides innovative solutions to increase the representation of racial and ethnic minorities in clinical trials. Labcorp works to build trust between communities with various engagement activities, including the Tigerlily Community Listening Summit to obtain information about breast, ovarian and cervical cancer patients to integrate into clinical trials and developing a best practice framework to make sites more inclusive.
The #InclusionPledge is one of many actions Tigerlily is taking to improve awareness, education, access, treatment delivery and outcomes, and resources for women with breast cancer. To date, the Inclusion Pledge has more than twelve thousand individual signatures and more than 90 commitments from companies and institutions.
To sign the #InclusionPledge for your organization, visit: https://www.tigerlilyfoundation.org/inclusionpledgeforblackwomen
About Tigerlily Foundation
Tigerlily Foundation is a national breast cancer foundation that provides education, awareness, advocacy and practical support to young women (ages 15-45) – before, during and after breast cancer. Tigerlily programs aim to educate and empower women of all backgrounds, including those at increased risk, those facing health disparities, and those with less access to care. Tigerlily improves quality of life and ends isolation for breast cancer survivors. Follow Tigerlily Foundation on LinkedIn and Twitter @Tigerlilycares.
Labcorp is a global life sciences leader that provides vital information to help physicians, hospitals, pharmaceutical companies, researchers and patients make informed decisions with confidence. Through our unparalleled diagnostic and drug development capabilities, we deliver insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve customers in over 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in 2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
Christopher Allman Bradshaw
Such. : 336-436-8263
Email: [email protected]
Such. : 336-436-5076
E: [email protected]